Pure Global
NCT06033274

Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment

Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment: the TRIPLACE Registry
Montefiore Medical Center·ClinicalTrials.gov·device·Device trialEnrolling by invitation
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Tricuspid Regurgitation
Drug/Device/Intervention
Transcatheter Tricuspid Valve Replacement
Study type
Observational
Intervention type
device
Sponsor & location
Primary sponsor
Montefiore Medical Center
Location
Bronx,Cleveland,Saint Thomas,Bordeaux, Canada,France,United States of America
Timeline & enrollment
Phase
N/A
Start date
Oct 05, 2023
End date
Aug 01, 2027
Enrollment
300 participants
Primary outcome

Freedom from device-related complications,Reduction in Tricuspid Regurgitation Severity

Summary

The field of transcatheter tricuspid valve replacement (TTVR) is rapidly emerging and data on
 this topic are scarce. Particularly, little is known about which patients are at greatest
 risk of procedural complications, such as the timing and onset of conduction disturbances
 necessitating permanent pacemaker implantation, and how such patients are managed. On this
 background, the TRIPLACE Registry - an investigator-initiated global multicenter registry -
 is aimed at better understanding the safety and efficacy of orthotopic TTVR.

ICD-10 classifications
Tricuspid stenosisTricuspid stenosis with insufficiencyNonrheumatic tricuspid (valve) stenosisTricuspid insufficiencyNonrheumatic tricuspid (valve) stenosis with insufficiency
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06033274
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06033274 through Pure Global AI's free database. This phase not specified trial is sponsored by Montefiore Medical Center and is currently Enrolling by invitation. The study focuses on Tricuspid Regurgitation. Target enrollment is 300 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.